BORSANI, Oscar
 Distribuzione geografica
Continente #
NA - Nord America 842
AS - Asia 839
EU - Europa 396
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 36
OC - Oceania 1
Totale 2.441
Nazione #
US - Stati Uniti d'America 806
BR - Brasile 220
SG - Singapore 215
CN - Cina 205
VN - Vietnam 161
HK - Hong Kong 147
RU - Federazione Russa 95
DE - Germania 69
IT - Italia 67
FR - Francia 43
FI - Finlandia 33
GB - Regno Unito 27
AR - Argentina 23
ZA - Sudafrica 19
IE - Irlanda 17
MX - Messico 17
ID - Indonesia 15
IN - India 15
AT - Austria 12
CA - Canada 11
EC - Ecuador 11
BD - Bangladesh 10
JP - Giappone 10
CH - Svizzera 8
IQ - Iraq 8
TR - Turchia 8
MA - Marocco 7
MY - Malesia 6
IL - Israele 5
VE - Venezuela 5
AZ - Azerbaigian 4
CO - Colombia 4
NL - Olanda 4
PK - Pakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
EG - Egitto 3
ES - Italia 3
KG - Kirghizistan 3
LT - Lituania 3
PH - Filippine 3
PL - Polonia 3
SE - Svezia 3
CR - Costa Rica 2
CZ - Repubblica Ceca 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LK - Sri Lanka 1
PE - Perù 1
QA - Qatar 1
UA - Ucraina 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.385
Città #
Hong Kong 140
Dallas 128
Singapore 110
San Jose 109
Ashburn 86
Council Bluffs 70
Beijing 64
Ho Chi Minh City 63
New York 38
Munich 37
Lauterbourg 32
Hanoi 30
Shanghai 28
Los Angeles 25
Moscow 25
Boardman 22
Helsinki 21
Columbus 20
Redondo Beach 20
Dublin 17
Santa Clara 17
Johannesburg 16
São Paulo 15
Orem 12
Turku 12
Frankfurt am Main 11
Buffalo 10
Catania 10
Chandler 10
Tokyo 10
Da Nang 9
Denver 8
Nuremberg 8
Rio de Janeiro 8
Rome 8
Milan 7
Haiphong 6
Houston 6
London 6
The Dalles 6
Baghdad 5
Brooklyn 5
Chennai 5
Curitiba 5
Düsseldorf 5
Jakarta 5
Pavia 5
Poplar 5
Vienna 5
Baku 4
Bắc Ninh 4
Campinas 4
Can Tho 4
Mexico City 4
Montreal 4
Seattle 4
Sorocaba 4
Ankara 3
Bishkek 3
Biên Hòa 3
Brugherio 3
Buenos Aires 3
Camaçari 3
Casablanca 3
Chicago 3
Falkenstein 3
Fortaleza 3
Guangzhou 3
Hải Dương 3
Lugano 3
Ninh Bình 3
Quito 3
Ribeirão Preto 3
Sahāranpur 3
Salt Lake City 3
Salvador 3
San Francisco 3
Stockholm 3
Tashkent 3
Tel Aviv 3
Turin 3
Viganello 3
Atlanta 2
Belgrade 2
Belém 2
Boston 2
Brasília 2
Cabo Frio 2
Cairo 2
Cape Town 2
Caracas 2
Caxias do Sul 2
Changsha 2
Chengdu 2
Colombo 2
Cornaredo 2
Córdoba 2
Dongguan 2
Elk Grove Village 2
Goiânia 2
Totale 1.468
Nome #
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 113
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis 109
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 97
COVID-19 in Patients with Hematologic Diseases 92
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 91
Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver 91
Hepatic iron is the major determinant of serum ferritin in NAFLD patients 81
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms 77
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms 75
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients 74
Isolated congenital asplenia: An overlooked cause of thrombocytosis 73
Clearance of Driver Mutations in Myelofibrosis 73
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms 71
Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation 70
Germline MPL mutations may be a rare cause of "triple-negative" thrombocytosis 70
Erythrocytosis in congenital heart defects: hints for diagnosis and therapy from a clinical case 69
Breakthrough infections in MPN-COVID vaccinated patients 66
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts 66
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts 64
Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy 62
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19 58
Wandering Spleen: An Unusual Cause of Recurrent Abdominal Pain 57
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score 56
Eradication of Measurable Residual Disease in AML: A Challenging Clinical Goal 55
Stormorken Syndrome Caused by a p.R304W STIM1 Mutation: The First Italian Patient and a Review of the Literature 55
Endosteal vessel integrity: a new therapeutic goal in acute myeloid leukemia? 55
Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms 53
Immune Escape after Hematopoietic Stem Cell Transplantation (HSCT): From Mechanisms to Novel Therapies 50
Incidence of blast phase in myelofibrosis according to anemia severity 48
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project 47
Long-term follow-up of recovered MPN patients with COVID-19 45
The evolutionary journey from essential thrombocythaemia to acute erythroid leukaemia 43
Second versus first wave of COVID-19 in patients with MPN 43
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients 43
Primary Budd-Chiari Syndrome 38
Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment 37
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study 14
Characterization of a Newly Discovered Non-Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis 13
CHEK2 Germline Variants in Early-Onset and Familial Myeloproliferative Neoplasms 13
Antigenic-Specificity and Cytokine Profile of the T-Cell Response to Human Cytomegalovirus in Transplant Recipients 12
A New t(8;9) Translocation Involving the JAK2 Gene in Acute Myeloid Leukemia: A Case Report 12
Maladaptive somatic gene rescue as predisposition to JAK2 molecular abnormalities? Insights from an Israeli family 10
Totale 2.441
Categoria #
all - tutte 10.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 1 0 0 1 5
2022/202362 4 4 0 2 2 2 0 2 15 0 27 4
2023/2024194 11 28 9 8 19 61 23 10 6 6 9 4
2024/2025556 20 23 8 2 1 19 44 24 123 33 65 194
2025/20261.522 112 116 240 278 152 29 188 53 148 94 71 41
2026/202797 32 65 0 0 0 0 0 0 0 0 0 0
Totale 2.441